SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: atticus4paws who wrote (2510)6/10/1999 1:54:00 PM
From: Joe  Read Replies (2) of 4140
 
Chris,

In my opinion, there is no question. SNRS will receive Panel recommendation for approval and FDA approval. The Panel will happen July 22/23. Approval will occur 2 to 6 months later. My guess, based on prior ODP recommendations, is that it will be 3 months.

I know LTK is safe and effective. I have had my eyes treated. I know the clinical trial data meets or exceeds what FDA expects. The clinical trial data presentation is posted on the SNRS website. sunrise-tech.com

The shorts got a boost yesterday because of a report done by Sturza. I understand it is similar to the one done by the Swiss analyst. The analysts involved did not even call the company or talk to any of the clinical investigators.

A boost for the shorts is a buying opportunity for the longs. I am very long but picked up more today at 11 5/8s. I will continue to buy if it goes any lower.

Regards,

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext